Skip to content

Pitofsky Jason

Reporting owner on Forms 3, 4 and 5, CIK 2009236.

Pitofsky Jason reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-06.

Issuers

IssuerRoles in the latest filingFilingsLast filed
REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589officer (SVP Controller)12026-11-06

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04M exercised+1,500$726.535,772Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04M exercised+1,478$644.547,250Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04M exercised+905$4928,155Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-439$939.577,716Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-575$940.467,141Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-982$941.586,159Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-1,215$942.314,944Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-529$943.534,415Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-108$944.224,307Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-35$945.614,272Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock2026-11-04S sold-179$950.760Form 4
REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding 48Form 4
REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative2026-11-04M exercised-905$00Form 4
REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative2026-11-04M exercised-1,478$0500Form 4
REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative2026-11-04M exercised-1,500$02,478Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0002009236-26-000003 REGENERON PHARMACEUTICALS, INC.2026-11-06